Does USTEKINUMAB Cause Skin plaque? 103 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Skin plaque have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.1% of all adverse event reports for USTEKINUMAB.
103
Reports of Skin plaque with USTEKINUMAB
0.1%
of all USTEKINUMAB reports
4
Deaths
23
Hospitalizations
How Dangerous Is Skin plaque From USTEKINUMAB?
Of the 103 reports, 4 (3.9%) resulted in death, 23 (22.3%) required hospitalization.
Is Skin plaque Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Skin plaque?
SECUKINUMAB (2,073)
ETANERCEPT (778)
OMALIZUMAB (607)
ADALIMUMAB (597)
METHOTREXATE (535)
RISANKIZUMAB-RZAA (278)
CYCLOSPORINE (276)
CLOBETASOL (227)
DUPILUMAB (200)
TRIAMCINOLONE (156)
Which USTEKINUMAB Alternatives Have Lower Skin plaque Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE